about
Prostate cancer stem cellsLow temperature plasmas as emerging cancer therapeutics: the state of play and thoughts for the futureLow temperature plasma: a novel focal therapy for localized prostate cancer?Differential cytotoxic activity of a novel palladium-based compound on prostate cell lines, primary prostate epithelial cells and prostate stem cellsLow-temperature plasma treatment induces DNA damage leading to necrotic cell death in primary prostate epithelial cellsMechanisms of growth inhibition of primary prostate epithelial cells following gamma irradiation or photodynamic therapy include senescence, necrosis, and autophagy, but not apoptosisApoptosis associated with deregulated E2F activity is dependent on E2F1 and Atm/Nbs1/Chk2.Regulation of the stem cell marker CD133 is independent of promoter hypermethylation in human epithelial differentiation and cancer.DNA hypermethylation in prostate cancer is a consequence of aberrant epithelial differentiation and hyperproliferation.An Epigenetic Reprogramming Strategy to Resensitize Radioresistant Prostate Cancer Cells.Stem cells and the role of ETS transcription factors in the differentiation hierarchy of normal and malignant prostate epithelium.The M30 assay does not detect apoptosis in epithelial-derived cancer cells expressing low levels of cytokeratin 18.Development and limitations of lentivirus vectors as tools for tracking differentiation in prostate epithelial cells.Harvesting Human Prostate Tissue Material and Culturing Primary Prostate Epithelial Cells.Transcriptional control by the R-transactivator protein of alcelaphine herpesvirus-1.E2F1 induces MRN foci formation and a cell cycle checkpoint response in human fibroblasts.Inhibition of the PI3K/AKT/mTOR pathway activates autophagy and compensatory Ras/Raf/MEK/ERK signalling in prostate cancerLow Temperature Plasma Causes Double-Strand Break DNA Damage in Primary Epithelial Cells Cultured from a Human Prostate Tumour.HDAC inhibitor confers radiosensitivity to prostate stem-like cellsTelomerase Activity and Telomere Length in Human Benign Prostatic Hyperplasia Stem-like Cells and Their Progeny Implies the Existence of Distinct Basal and Luminal Cell Lineages.Prostate cancer stem cells: do they have a basal or luminal phenotype?Phenotype-independent DNA methylation changes in prostate cancerEffects on prostate cancer cells of targeting RNA polymerase IIIEpigenetic Control of Gene Expression in the Normal and Malignant Human Prostate: A Rapid Response Which Promotes Therapeutic Resistance.Notch signalling is a potential resistance mechanism of progenitor cells within patient-derived prostate cultures following ROS-inducing treatments
P50
Q24654712-F75D36F9-F4BD-4B54-B408-658905614132Q26765057-5F304C54-D354-4778-A9D1-162E92B4844FQ27027563-65E4FA5B-C437-4E7F-B7B5-5A3732285F0BQ28487918-28D4AD2D-3D4F-4588-97A1-F0DA9F9ACBEAQ33464674-650BB01D-4C81-48B5-9754-0DF81431B041Q36451532-DB1E3613-7F86-4E9C-BF82-D02D8816A80CQ37011615-587D05DB-7738-4E48-893F-AD2636903758Q38264665-C126F9E3-2BF2-44AA-8C06-572AD1B02100Q38642046-5F05282C-5359-451B-90AC-33A90EB569FAQ38785671-B9A3FD9C-1ABE-4FD9-87CD-DF4984A3AE98Q38835895-582A2451-4E7C-4608-B0C8-5CD49B033FFFQ38890416-8EC5F261-54CB-4F5F-B740-A8604BDC84BEQ39665034-1FE86A31-9FFB-4293-9E43-9BD3F1564AE9Q39720960-25E5792C-260C-4E55-B98F-6BE6D4E2D43EQ40047761-38DC085F-20EA-4F40-A565-59C0481C5E3DQ40325397-4861EF64-63E8-49BB-9996-779489CDD852Q41345175-4D01F569-A4AD-4B13-847D-0A1D626D840CQ42180931-10C27D18-B7AB-4367-81BD-7FC363BD0D06Q42448602-461B0E8E-E40B-470A-9FDF-9156D5119141Q42483576-90AADC4B-5FB9-4231-A810-A226A806EC73Q42491578-2510F8DD-45DC-4ED4-BD99-8DEE4CC1A8C0Q57461611-572BABBC-3613-4F49-B5EB-48F01E313C1CQ64083073-0D88E9E0-EF68-4E82-AA08-57C973AB8D3CQ64911207-DB961180-AF90-432E-A67F-6140416C44B2Q93003838-24229E05-79FE-4AB1-9870-5C788F8CC26A
P50
description
investigador
@es
researcher
@en
name
Fiona M Frame
@en
Fiona M Frame
@nl
type
label
Fiona M Frame
@en
Fiona M Frame
@nl
prefLabel
Fiona M Frame
@en
Fiona M Frame
@nl
P31
P496
0000-0002-2377-1110